- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05274399
Hopelessness and Self-care Power in Hemodialysis Patients
March 27, 2023 updated by: Cihat Demirel, Muş Alparlan University
The Correlation Between The Hopelessness Level and Self-Care Agency In Patients Receiving Hemodialysis Treatment
The purpose of this study is to investigate the correlation between hopelessness level and self-care agency in patient receiving hemodialysis treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
While the symptoms and signs that occur as a result of renal failure can be controlled with hemodialysis treatment, the reasons such as the nature of the disease, disease-related symptoms, treatment period and patients' dependency on the hemodialysis machine due to this treatment lead to many physical and psychological problems in the patients.
Patients undergoing hemodialysis face physical problems such as becoming dependent, impairment of the socio-economic status, inability to fulfill their role in the society, and changes in work life and various psychological problems such as anxiety, depression, isolation, rejection of the disease, delusions, and hallucinations.
it is hoped that this study aiming to determine whether or not there is a correlation between hopelessness level and self-care agency of hemodialysis patients would make a great contribution to the limited available literature.
Study Type
Observational
Enrollment (Actual)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Muş, Turkey
- Muş Alparslan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The population of the study consisted of 75 patients registered in the hemodialysis unit of this university hospital, and the sample of the study consisted of 69 patients who were treated in this hospital and voluntarily accepted to participate in the study.
Description
Inclusion Criteria:
- Being 18 years or older,
- To be receiving hemodialysis treatment for at least three months,
- Not having mental confusion or having any psychiatric problems,
- Hearing-sight (except for those who use glasses)-speech problem
- Volunteering to participate in the research
Exclusion Criteria:
- Being 18 years or younger,
- have cognitive impairments,
- not being able to complete the questionnaires,
- not wanting to participate in the study,
- having decided to leave the job
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Hemodialysis Patients
Receiving hemodialysis treatment for at least three months
|
The data containing the questions determining the relationship between the self-care power and hopelessness of the patients who voluntarily participated in the study were collected through a questionnaire.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Information Form
Time Frame: one week after obtaining permission from the institution
|
Age, gender, marital status, educational status, employment status, occupation, income level, family type, disease characteristics; Duration of hemodialysis treatment, presence of other chronic diseases, family history of kidney disease, weekly hemodialysis duration (daytime)
|
one week after obtaining permission from the institution
|
Beck Hopelessness Scale (BHS)
Time Frame: one week after obtaining permission from the institution
|
Beck Hopelessness Scale (BUS), to determine the level of pessimism about the future of the individual for the purpose of It consists of 20 items expressed as yes and no.
|
one week after obtaining permission from the institution
|
Self-Care Agency Scale
Time Frame: one week after obtaining permission from the institution
|
It consists of 22 items scored between 0-2 in order to evaluate the self-care status of patients receiving long-term dialysis treatment.
|
one week after obtaining permission from the institution
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 14, 2020
Primary Completion (Actual)
May 10, 2020
Study Completion (Actual)
October 20, 2020
Study Registration Dates
First Submitted
March 1, 2022
First Submitted That Met QC Criteria
March 1, 2022
First Posted (Actual)
March 10, 2022
Study Record Updates
Last Update Posted (Actual)
March 28, 2023
Last Update Submitted That Met QC Criteria
March 27, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- E.1337
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Time Frame
no time limit
IPD Sharing Access Criteria
All data
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis
-
National Taiwan University HospitalCompletedHemodialysis Complication | Hemodialysis-Induced SymptomTaiwan
-
Ain Shams UniversityCompleted
-
Imperial College Healthcare NHS TrustCompletedHemodialysisUnited Kingdom
-
Lawson Health Research InstituteUnknown
-
Tufts Medical CenterWithdrawn
-
Federico II UniversityUnknown
-
Hospital Clinic of BarcelonaSocietat Catalana de NefrologiaCompleted
-
Brigham and Women's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Angion Biomedica CorpNucleus Network LtdNot yet recruitingHemodialysisUnited States
Clinical Trials on surveys and questionnaires
-
RenJi HospitalFirst People's Hospital of Hangzhou; Huashan Hospital; First Affiliated Hospital... and other collaboratorsRecruitingPeripheral Arterial DiseaseChina
-
Anna CygańskaActive, not recruitingMusculoskeletal Pain | QuestionnairePoland
-
Women's College HospitalCompletedCaregiver BurnoutCanada
-
Pamukkale UniversityCompletedHealthy | Health, SubjectiveTurkey
-
M.D. Anderson Cancer CenterRecruitingCancer-related Venous ThromboembolismUnited States, Colombia, Spain
-
M.D. Anderson Cancer CenterPatient-Centered Outcomes Research InstituteCompleted
-
M.D. Anderson Cancer CenterCompleted
-
University of SalamancaNot yet recruiting
-
M.D. Anderson Cancer CenterActive, not recruitingMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign NeoplasmsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMultiple Endocrine Neoplasia SyndromesUnited States